Improvement of atopic dermatitis and alopecia universalis with dupilumab

Dupilumab is an interleukin-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis and alopecia totalis after dupilumab treatment for AD. We present one of reported cases that...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Lama, Alfawzan, Abdulrahman, Alharthi, Raghad, Al sheikh, Afaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251532/
https://www.ncbi.nlm.nih.gov/pubmed/35795833
http://dx.doi.org/10.4081/dr.2022.9359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251532/
https://www.ncbi.nlm.nih.gov/pubmed/35795833
http://dx.doi.org/10.4081/dr.2022.9359

Ejemplares similares